鲍会静 - 天津医科大学 - 医学检验学院

个人简介

教育背景 2002.9–2006.7 苏州大学生物技术 2003.8–2005.7 Troy state university 细胞和分子生物学学士 2007.9–2010.7 南开大学微生物硕士 2012.7–2015.9 天津医科大学临床检验诊断学博士 2013.3–2014.2 University of Pennsylvania医学院转化医学中心博士工作经历 2013.1- 天津医科大学医学检验学院讲师 2010.9-2012.12 天津医科大学医学检验学院助教荣誉奖励 2011年天津医科大学青年教师讲课大赛二等奖 2015年度天津市“131”创新型人才培养工程第三层次人选

研究领域

肿瘤诊断与靶向治疗

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1. HuijingBao, Chengfeng Bi, Wei Li, Xuhan Zhang,Huilai Zhang, Bin Meng and KaiFu*.Chimeric Antigen Receptor-Engineered Exosome As a Drug Delivery System in Mantle Cell Lymphoma. 59th Annual Meeting and Exposition, Atlanta, GA. Blood, December 9-12, 2017,pub 2. Qin Yuan, Jiayin Song, Weiwei Yang, Hongyan Wang, QianyuHuo, Jie Yang, Xiaoxu Yu, Yunde Liu, Chen Xu and HuijingBao*. The effect of CA125 on metastasis of ovarian cancer: Old marker new function. Oncotarget. 2017.06.17. doi: 10.18632/oncotarget.1838 3. Xiaopeng Yuan，Mingjuan Yang，Xiang Chen，Xuhua Zhang，ShreySukhadia，NajiaMusolino，HuijingBao，Tingtao Chen，Chen Xu，Qirui Wang，Stephen Santoro，Daniel Ricklin，Jia Hu，Ruihe Lin，Wei Yang，Zhijun Li，Weijun Qin，Aizhi Zhao，Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy，Cancer Immunology, Immunotherapy，2016.12.08，s00262：016~1937 4. Chen Xu，Nan Zhang，QianyuHuo，Minghui Chen，Rengfeng Wang，Zhili Liu，Xue Li，Yunde Liu，HuijingBao*. Polymerase chain reaction–hybridization method using urease gene sequences for high-throughput Ureaplasmaurealyticum and Ureaplasmaparvum detection and differentiation，Analytical Biochemistry，2016.2.25，499：57~62 5.HuijingBao, Xiaoxu Yu, Chen Xu, Xue Li, et al. New Toxicity Mechanism of Silver Nanoparticles: Promoting Apoptosis and Inhibiting Proliferation. PloS One. 2015 Mar 30 10(3) 6. Yu Qin, HuijingBao(co-first author), Yi Pan, et al. SUMOylation alterations are associatedwith multidrug resistance in hepatocellular carcinoma. molecular medicine reports 9:877-881,2014